1 tracked superinvestor hold Belite Bio Inc Sponsored (BLTE), worth $16M combined, led by Stanley Druckenmiller. Smart money is holding BLTE as of the latest 13F filings.
Current price
$193.61
+197.2%
1Y
Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapies. The firm's primary therapeutic areas include atrophic age-related macular degeneration and autosomal recessive Stargardt disease. Its flagship drug candidate, LBS-008, is an investigational oral medication administered once daily. Currently undergoing Phase 3 clinical…
Market cap
$6.2B
P/E
-66.75
Div yield
0.0%
Revenue YoY
0.0%
Analyst target
$238
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$16M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
0
0 buying · 0 selling
Smart money is holding BLTE steady this quarter — buys and sells are balanced.
Belite Bio Inc Sponsored (BLTE) is held by 1 tracked funds worth $16M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Stanley Druckenmiller at 0.3% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
Tracked holders were largely static this quarter — no new opens, adds or trims of size — suggesting the position is being held rather than actively traded.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Held | 0.3% | $16M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own BLTE?
1 tracked funds hold Belite Bio Inc Sponsored (BLTE), the largest being Stanley Druckenmiller (Duquesne Family Office) at 0.3% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling BLTE?
In the most recent 13F quarter, 0 tracked funds added or opened BLTE and 0 trimmed it.
How much BLTE do tracked funds hold?
Combined disclosed long exposure to BLTE across tracked superinvestors is $16M as of the Jun 2026 filings.
One email when a tracked manager opens, adds to or files to sell a position — from Form 4, 13D and Form 144, not the 45-day-old 13F.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Jun 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.